Dermapharm - Pharmaceutical Excellence “Made in Germany”:
Dermapharm is a leading manufacturer of patent-free branded pharmaceuticals for selected markets in Germany.
Founded in 1991, the company is based in Grünwald near Munich and has its main manufacturing facility in Brehna
near Leipzig. The company’s integrated business model comprises in-house development, in-house production and
distribution of pharmaceuticals and other healthcare products for specifically targeted markets by a medical
and pharmaceutical sales force. Dermapharm holds approximately 900 marketing authorizations (Arzneimittelzulassungen)
for more than 250 active pharmaceutical ingredients, which are marketed as pharmaceuticals, dietary supplements or
supplemental balanced diets. This assortment makes the company unique. In addition to Germany, the company’s core
markets also include Austria and Switzerland. The company plans to further expand its international presence.
Dermapharm’s business model also includes a parallel import business, which operates under the “axicorp” brand.
Based on revenues, Dermapharm was among the top five parallel import companies in Germany in 2018.
With a consistent development strategy and numerous successful product and company acquisitions over the
past 25 years, Dermapharm has continuously optimized its business and provided external growth impulses in
addition to organic growth. Dermapharm intends to continue this profitable growth course in the future. The
company is focusing on a three-pillar strategy: in-house development of new products, increase of its
international footprint and further acquisitions.